Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?

American Journal of Medicine

Volumn 118, Issue 8, 2005, Pages 816-826

  Baker, Joshua F ^a   Krishnan, Eswar ^b   Chen, Lan ^a   Schumacher, H Ralph ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Risk factor; Uric acid

Indexed keywords

ATENOLOL; ATORVASTATIN; LOSARTAN; URIC ACID;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBASE; FEMALE; HUMAN; HYPERURICEMIA; MALE; MEDICAL LITERATURE; MEDLINE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; URIC ACID BLOOD LEVEL;

CARDIOVASCULAR DISEASES; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; RISK FACTORS; URIC ACID;

EID: 23244462442     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.03.043     Document Type: Review

References (102)

1. H.M. Lakka, D.E. Laaksonen, T.A. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 21 2002 2709 2716
2. G. Reaven Role of insulin resistance in human disease Diabetes 37 12 1988 1595 1607
3. R.A. DeFronzo, E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 3 1991 173 194
4. A. Fam Gout, diet, and the insulin resistance syndrome J Rheumatol 29 7 2002 1350 1355
5. J. Sowers Update on the cardiometabolic syndrome Clin Cornerstone 4 2 2001 17 23
6. H.S. Kahn, R. Valdez Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration Am J Clin Nutr 78 5 2003 928 934
7. J. Meigs The metabolic syndrome BMJ 327 2003 61
8. P.H. Dessein, E.A. Shipton, A.E. Stanwix, B.I. Joffe, J. Ramokgadi Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout a pilot study Ann Rheum Dis 59 2000 539 543
9. R.J. Johnson, B.A. Rideout Uric acid and diet - insights into the epidemic of cardiovascular disease N Engl J Med 350 11 2004 1071 1073
10. D. Conen, V. Wietlisbach, P. Bovet Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country BMC Public Health 4 2004 9
11. J.C. Ter Maaten, A. Voorburg, R.J. Heine, P.M. Ter Wee, A.J. Donker, R.O. Gans Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects Clin Sci Lond 92 1997 51 58
12. A.Q. Galvan, S. Baldi Effect of insulin on uric acid excretion in humans NA Am J Physiol 268 1995 E1 E5
13. R.J. Johnson, D. Feig Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? KD Hypertension 41 2003 1183 1190
14. P.J. Cannon, W.B. Statson, F.E. Demartini, S.C. Sommers, J.H. Laragh Hyperuricemia in primary and renal hypertension N Engl J Med 275 1966 457 464
15. F.H. Messerli, E.D. Frohilich, G.R. Dreslinski, D.H. Suarez, G.G. Arisimuno Serum uric acid in essential hypertension an indicator of renal vascular involvement Arch Intern Med 93 1980 817 821
16. W. Kannel Metabolic risk factors for coronary heart disease in women. perspective from the Framingham study Am Heart J 114 1987 413 419
17. R.D. Abbot, F.N. Brand, W.B. Kannel, W.P. Castelli Gout and coronary heart disease the Framingham study J Clin Epidemiol 41 1988 237 242
18. V.W. Persky, A.R. Dyer, E. Idris-Soven Uric acid a risk factor for coronary heart disease? Circulation 59 1979 969 977
19. W. Levine, A.R. Dyer, R.B. Shekelle, J.A. Shoenberger, J. Stamler Serum uric acid and 11.5-year mortality of middle-aged women findings of the Chicago Heart Association Detection Project in Industry J Clin Epidemiol 42 1989 257 267
20. D.S. Freedman, D.F. Williamson, E.W. Gunter, T. Byers Relation of serum uric acid to mortality and ischemic heart disease the NHANES I Epidemiologic Follow-up Study Am J Epidemiol 141 1995 637 644
21. A. Reunanen, H. Takkunen, P. Knekt, A. Aromaa Hyperuricemia as a risk factor for cardiovascular mortality Acta Med Scand 668 1982 49 59
22. S.G. Wannamethee, A.G. Shaper, P.H. Whincup Serum urate and the risk of major coronary heart disease events Heart 78 1997 147 153
23. J. Staessen The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial Am J Med 90 1991 50S 53S
24. Coronary Drug Project Research Group Serum uric acid its association with other risk factors and with mortality in coronary heart disease J Chron Dis 29 1976 557 569
25. A. Kagan, T. Gordon, G.G. Rhoads, J.C. Schiffman Some factors related to coronary heart disease incidence in Honolulu Heart study Int J Epidemiol 4 1975 271 279
26. R.J. Goldberg, C.M. Burchfiel, R. Benfante, D. Chiu, D.M. Reed, K. Yano Lifestyle and biologic factors associated with atherosclerotic disease in middle aged men Arch Intern Med 155 1995 686 694
27. C. Iribarren, D.S. Sharp, J.D. Curb, K. Yano High uric acid a metabolic marker or coronary heart disease among alcohol abstainers? J Clin Epidemiol 49 1996 673 678
28. W.B. Duffy, H.O. Sennekjian, T.F. Knight, E.J. Weinman Management of asymptomatic hyperuricemia JAMA 246 1981 2215 2216
29. M. Alderman Uric acid and cardiovascular risk Curr Opin Pharmacol 2 2002 126 130
30. R.J. Johnson, K.R. Tuttle Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease Hypertension 35 2000 E10
31. B.F. Culleton, M.G. Larson, W.B. Kannel, D. Levy Serum uric acid and risk of cardiovascular disease and mortality the Framingham Heart Study Ann Intern Med 31 1999 7 13
32. J.T. Moriarity, A.R. Folsom, C. Iribarren, F.J. Nieto, W.E. Rosamond Serum uric acid and risk of coronary heart disease atherosclerosis risk in communities (ARIC) Study Ann Epidemiol 10 2000 136 143
33. S.H. Jee, S.Y. Lee, M.T. Kim Serum uric acid and risk of death from cancer cardiovascular disease or all causes in men Eur J Cardiovasc Prev Rehabil 11 3 2004 185 191
34. J. Fang, M.H. Alderman Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow up study, 1971-1992 JAMA 283 2000 2404 2410
35. P. Hu, T.E. Seeman, T.B. Harris, D.B. Reuben Is serum uric acid level associated with all-cause mortality in high-functioning older persons MacArthur studies of successful aging? J Am Geriatr Soc 49 2001 1679 1684
36. A. Mazza, A.C. Pessina, A. Pavei, R. Scarpa, V. Tikhonoff, E. Casiglia Predictors of stroke mortality in elderly people from the general population. The Cardiovascular Study in the Elderly Eur J Epidemiol 17 2001 1097 1104
37. A.C. Aboa Eboule, P. De Smet, M. Dramaix, G. De Backer, M. Kornitzer Relation between uricemia and all-causes cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population Revue d Epidemiologie et de Sante Publique 49 6 2001 531 539
38. A.D. Liese, H.-W. Hense, H. Lowel, A. Doring, M. Tietze, U. Keil Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg Cohort Epidemiology 10 1999 391 397
39. P.E. Puddu, M. Lanti, A. Menotti Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study Acta Cardiologica 56 4 2001 243 251
40. M.H. Alderman, H. Cohen, S. Madhavean, S. Kivlighn Serum uric acid and cardiovascular events in successfully treated hypertensive patients Hypertension 34 1999 144 150
41. L.V. Franse, M. Pahor, M. Di Bari Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program(SHEP) J Hypertens 188 8 2000 1149 1154
42. H.G. Langford, M.D. Blaufox, N.O. Borhani Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program Arch Intern Med 147 1987 645 649
43. C.S. Wingrove, C. Walton, J.C. Stevenson The effect of menopause on serum uric acid levels in non-obese healthy women Metabolism 47 1998 435 438
44. P.W. De Leeuw, L. Thijs, W.H. Birkenhager Prognostic significance of renal function in elderly patients with isolated systolic hypertension results from the Syst-Eur Trial J Am Soc Nephrol 13 2002 2213 2222
45. N.S. Anavekar, J.J.V. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 13 2004 1285 1295
46. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
47. L.K. Niskanen, D.E. Laaksonen, K. Nyyssonen Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men Arch Intern Med 164 2004 1546 1551
48. P. Verdecchia, G. Schillaci, G.P. Reboldi, F. Santeusanio, C. Porcellati, P. Brunetti Relation between serum uric acid and risk of cardiovascular disease in essential hypertension the PIUMA Study Hypertension 36 2000 1072 1078
49. C.J. Weir, S.W. Muir, M.R. Walters, K.R. Lees Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke Stroke 34 2003 1951 1957
50. S. Lehto, L. Niskanen, T. Ronnemaa, M. Laakso Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus Stroke 29 1998 635 639
51. S.D. Anker, W. Doehner, M. Rauchhaus Uric acid and survival in chronic heart failure. Validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
52. C. Tseng Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes Diabet Med 21 2004 724 729
53. C. Bickel, H.J. Rupprecht, S. Blankenberg Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease Am J Cardiol 89 2002 12 17
54. M.H. Alderman, H. Cohen, W.B. Kivlighn, S. Madhavan Does treatment-mediated increase in uric acid reduce the cardioprotective effect of diuretics in hypertensive patients? Am J Hypertens 11 1998 16a
55. A. Chamorro, V. Obach, A. Cervera, M. Revilla, R. Deulofeu, J.H. Aponte Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke Stroke 33 2002 1048 1052
56. A. Cherubini, M.C. Polidori, M. Bregnocchi Antioxidant profile and early outcome in stroke patients Stroke 31 2000 2295 2300
57. W. Doehner, N. Schoene, M. Rauchhaus Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure results from 2 placebo-controlled studies Circulation 105 2002 2619 2624
58. J.-G. Wang, J.A. Staessen, R.H. Fagard, W.H. Birkenhager, L. Gong, L. Liu Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension Hypertension 37 2001 1069 1074
59. V.G. Athyros, M. Elisaf, A.A. Papageorgiou Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease a subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) Study Am J Kidney Dis 43 4 2004 589 599
60. A. Hoieggen, M.H. Alderman, S.E. Kjeldsen The impact of serum uric acid on cardiovascular outcomes in the LIFE study Kidney Int 65 2004 1041 1049
61. M. Manttari, E. Tiula, T. Alikoski Effects of hypertension and dyslipidemia on the decline in renal function Hypertension 26 1995 670 675
62. H. Gin, V. Rigalleau, M. Paraicio Lipids, protein intake, and diabetic nephropathy Diabetes Metab 26 2000 S45 S53
63. Daskalopoulou SS, V.G. Athyros, M. Elisaf, D.P. Mikhailidis Uric acid levels and vascular disease Curr Med Res Opin 20 6 2004 951 954
64. F. Youssef, A.M. Seifalian, I.A. Jagroop The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT) Eur J Vasc Endovasc Surg 23 2002 358 364
65. F. Youssef, P. Gupta, A.M. Seifalian, F. Myint, D.P. Mikhailidis, G. Hamilton The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease Angiology 55 2004 53 62
66. C. Guijarro, B.L. Kasiske, Y. Kim, M.P. O'Donnell, H.S. Lee, W.F. Keane Early glomerular changes in rats with dietary-induced hypercholesterolemia Am J Kidney Dis 26 1995 152 161
67. B. Dahlof, R.B. Devereaux, S.E. Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) a randomized trial against atenolol Lancet 359 2002 995 1003
68. B.A. Soffer, J.T. Wright, J.H. Pratt Effects of losartan on a background of hydrochlorothiazide in patients with hypertension Hypertension 22 1995 112 117
69. M. Burnier, F. Roch-Ramel, H.R. Brunner Renal effects of an angiotensin II receptor blockade in normotensive subjects Kidney Int 49 1996 1787 1790
70. M. Burnier, B. Rutschmann, J. Nussberger Salt dependent renal effects of an angiotensin II antagonist in healthy subjects Hypertension 22 1993 339 347
71. C. Chen, H. Wang, S.M. Snapinn Proportion of treatment effect (PTE) explained by a surrogate marker Stat Med 22 22 2003 2449 2459
72. N.A. Weimert, W.F. Tanke, J.J. Sims Allopurinol as a cardioprotective during coronary artery bypass graft surgery Ann Pharmacother 37 2003 1708 1711
73. T.P. Cappola, D.A. Kass, G.S. Nelson Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy Circulation 104 2001 2407 2411
74. A.D. Struthers, P.T. Donnan, P. Lindsay, D. McNaughton, J. Broomhall, T.M. Macdonald Effect of allopurinol on mortality and hospitalizations in congestive heart failure a retrospective cohort study Heart 87 2002 229 234
75. G. Mercuro, C. Vitale, E. Cerquetani, S. Zoncu, M. Fini, G.M.C. Rosano Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk Am J Cardiol 94 2004 932 935
76. L.G. Sanchez-Lozada, E. Tapia, C. Avila-Casado Mild hyperuricemia induces glomerular hypertension in normal rats Am J Physiol Renal Physiol 283 2002 F1105 F1110
77. M. Mazzali, J. Hughes, Y.G. Kim Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 2001 1101 1106
78. S. Watanabe, D.H. Kang, L. Feng Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity Hypertension 40 2002 355 360
79. M. Mazzali, J. Kanellis, L. Han Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol 282 2002 F991 F997
80. P. Mattei, F. Arzilli, R. Giovannetti Microalbuminuria and renal haemodynamics in essential hypertension Eur J Clin Invest 27 1997 755 760
81. I. Saito, T. Saruta, K. Kondo Serum uric acid and the rennin-angiotensin system in hypertension J Am Geriatr Soc 26 1978 241 247
82. D.I. Feig, R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 3 2003 247 252
83. F. Jossa, E. Farinaro, S. Panico Serum uric acid and hypertension the Olivetti heart study J Hum Hypertens 8 1994 677 681
84. A.R. Dyer, K. Liu, M. Walsh, C. Kiefe, D.R. Jacobs, D.E. Bild Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults J Hum Hypertens 13 1 1999 13 21
85. B. Emmerson Atherosclerosis and urate metabolism Aust NZ J Med 9 1979 451 454
86. H. Newland Hyperuricemia in coronary, cerebral and peripheral arterial disease an explanation Med Hypotheses 1 1975 152 155
87. M.H. Ginsberg, F. Kozin, M. O'Malley, D.J. McCarty Release of platelet constituents by monosodium urate crystals J Clin Invest 60 1977 999 1007
88. W.S. Waring, D.J. Webb, S.R.J. Maxwell Effect of local hyperuricemia on endothelial function in the human forearm vascular bed Br J Clin Pharmacol 49 2000 511
89. K. Kuwano, H. Ikeda, T. Oda Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis Am J Physiol 270 1996 1993 1999
90. J. Visy, P. Le-Coz, B. Chadefaux Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings Neurology 41 1991 1313 1315
91. F. Leyva, S. Anker, J.W. Swan Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure Eur Heart J 18 1997 858 865
92. S.D. Anker, F. Leyva, P.A. Poole-Wilson, W.J. Kox, J.C. Stevenson, A.J. Coats Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure Heart 78 1997 39 43
93. J. Vasquez-Vivar, A.M. Santos, V.B. Junqueira, O. Augusto Peroxynitrite-mediated formation of free radicals in human plasma EPR detection of ascorbyl, albumin-thiyl and uric acid derived free radicals Biochem J 314 1996 869 876
94. I.K. DeScheeder, A.M. van de Kraay, J.M. Lamers, J.F. Koster, J.W. deJong, P.W. Serruys Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during angioplasty potential mechanisms for free radical generation Am J Cardiol 68 1991 392 395
95. C. Iribarren, A.R. Folsom, J.H. Eckfeldt, P.G. McGovern, F.J. Nieto Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study: Atherosclerosis Risk In Communities Stroke 29 1999 635 639
96. C. Suarna, R.T. Dean, J. May, R. Stocker Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate Arterioscler Thromb Vasc Biol 15 1995 1616 1624
97. G.N. Rao, M.A. Corson, B.C. Berk Uric acid stimulates vascular smooth muscle proliferation by increasing platelet derived growth factor A-chain expression J Biol Chem 266 1991 8604 8608
98. N.J. Wald, H.C. Watt, M.R. Law Homocysteine and ischaemic heart disease Arch Intern Med 158 1998 862 867
99. D. Tanne Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease Stroke 34 2003 632 636
100. M. Milosevic-Tosic, J. Borota Hyperhomocysteinemia - a risk factor for development of occlusive vascular diseases Med Pregl 55 9-10 2002 385 391
101. O. Stanger, W. Herrmann, K. Pietrzik Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases Z Kardiol 93 6 2004 439 453
102. A. Hill The environment and disease association or causation? T Proc Royal Soc Med 58 1965 295 300